(Q51300679)

English

Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.

scientific article published on 25 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

atrial fibrillation

0 references

0 references

electrophysiology

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

7

object named as

Lars Eckardt

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Gerrit Frommeyer

1

object named as

Gerrit Frommeyer

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

author name string

Marco Schmidt

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Catharina Clauß

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Sven Kaese

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Jörg Stypmann

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Christian Pott

6

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Peter Milberg

8

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

publication date

25 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

14

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

12

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

1322-1331

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

Atrial remodeling and atrial fibrillation: mechanisms and implications.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Novel molecular targets for atrial fibrillation therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Electrophysiologic basis for the antiarrhythmic actions of ranolazine

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Verapamil prevents stretch-induced shortening of atrial effective refractory period in langendorff-perfused rabbit heart

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Use-dependent block of cardiac late Na(+) current by ranolazine

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Pathophysiology of the cardiac late Na current and its potential as a drug target

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Recent advances in the molecular pathophysiology of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Defective cardiac ryanodine receptor regulation during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Na(v)1.5: a novel mechanism of drug action

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Targeting myocardial substrate metabolism in heart failure: potential for new therapies

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Dronedarone in High-Risk Permanent Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS163

21 January 2018

Identifiers

10.1093/EURJHF/HFS163

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

release_hkdfdddhxfc6ri5lxeouf3ltci

1 reference

https://api.fatcat.wiki/v0/release/hkdfdddhxfc6ri5lxeouf3ltci

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/23099358

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51300679&oldid=2067366287"